Inc. (NASDAQ:ETNB), with a market capitalization of $1.14 billion, is a clinical-stage biopharmaceutical company focusing on the development of innovative therapies for the treatment of liver and ...
In-depth analysis of market report, which encompasses revenue estimations, key investment opportunities, trends, region insights, and competitive landscape. David Correa Allied Market Research + + 1 ...